0001772016-25-000153
SEC filingRevenue grew 16% to $2.32B driven by Premier Protein volume gains, but operating profit fell 8% due to $69M legal provision and higher costs.
BellRing Brands, Inc. describes itself as a leader in the global convenient nutrition category. The company's purpose is to enhance consumers' lives by providing nutritious, great-tasting products that can be enjoyed throughout the day. Its primary brands are Premier Protein and Dymatize, which together generated $2,316.6 million in net sales in the year ended September 30, 2025, up from $1,666.8 million in fiscal 2023. The company operates in a rapidly growing category within the food and beverage industry, with the U.S. as its primary market.
The filing does not disclose formal reporting segments. Instead, the company reports net sales by brand: Premier Protein accounted for 85.9%, Dymatize for 12.1%, and other brands for 2.0% of fiscal 2025 net sales. Two product forms dominated: RTD protein shakes at 81.7% and powders at 15.8%.
The flagship brand, Premier Protein, offers RTD protein shakes and protein powders. Its shakes contain 30 grams of protein and 160 calories, are gluten- and soy-free, low in sugar and fat, and fortified with vitamins and minerals. The Dymatize brand targets fitness enthusiasts with science-based sports nutrition products, primarily protein powders. Key Dymatize products include ISO.100 (hydrolyzed 100% Whey Protein Isolate), Elite 100% Whey, and Super Mass Gainer. The company also owns the PowerBar brand and has licensed trademarks such as Pebbles and Dunkin.
The U.S. business represented 88.1% of fiscal 2025 net sales. The company sells through a diverse network of channels: club, food/drug/mass (FDM), eCommerce, specialty, and convenience. In the U.S., a direct sales force covers club, FDM, specialty, and eCommerce; broker networks serve convenience and regional grocery; distributors handle foodservice and military. Internationally, the company uses direct sales in key Western European markets and distributors. Customer concentration is high: Walmart (including Sam's Club), Costco, and Amazon collectively account for approximately 74% of net sales, with no other customer exceeding 10%.
The convenient nutrition category is highly competitive and sensitive to pricing and promotion. Competitors include branded and private label products from manufacturers of varying sizes, some with substantially more resources. Competition is based on product quality, taste, functional benefits, nutritional value, convenience, brand loyalty, shelf space, price, and promotional activities. The company’s principal competitive strategies include strong marketing, customer relationship management, category insights, product quality and safety, innovation, supply chain efficiency, and competitive pricing.
The company's strategic priorities are embedded in its operations: building brand awareness through impactful marketing (e.g., Premier Protein's broad media strategy and influencer program 'Premier Shakers'; Dymatize's social media and athlete influencer model), managing key customer relationships, investing in product innovation (new flavors, ingredients, packaging, and process technologies), maintaining superior product quality and food safety through rigorous standards, and ensuring an efficient and resilient supply chain. The company continuously plans for incremental manufacturing capacity and evaluates strategic alternatives to support growth.
As of November 1, 2025, BellRing had approximately 530 employees, with about 350 in the U.S., 170 in Germany, and 10 in other countries. The company emphasizes a safe, rewarding workplace and provides training, development programs, competitive compensation and benefits, and fosters a culture of belonging. Health and safety protocols are in place, especially at the Voerde, Germany manufacturing facility.
For the fiscal year ended September 30, 2025, BellRing Brands reported net sales of $2,316.6 million, a 16% increase from $1,996.2 million in the prior year. The growth was driven by strong volume gains in both the Premier Protein and Dymatize brands, with Premier Protein up 17% (15% volume growth) and Dymatize up 13% (23% volume growth). Average net selling prices increased for Premier due to targeted price increases but decreased for Dymatize due to unfavorable product mix.
Operating profit declined 8% to $357.4 million from $387.7 million, despite the top-line growth. The decrease was primarily attributable to a $69.0 million provision for legal matters, $72.1 million in higher net product costs (raw materials and manufacturing, partially offset by lower freight), increased advertising expense of $13.9 million, and higher warehousing and distribution costs of $12.0 million. These headwinds were partially offset by the prior year's $17.4 million accelerated amortization related to the PowerBar discontinuance and the benefit of higher sales. The operating margin contracted to 15.4% from 19.4%.
Net earnings fell 12% to $216.2 million from $246.5 million, driven by lower operating profit and higher net interest expense ($68.4 million vs. $58.3 million), partially offset by a lower income tax expense ($72.8 million vs. $82.9 million). The effective tax rate remained flat at 25.2%.
BellRing operates as a single reportable segment, but the MD&A provides brand-level revenue detail. Premier Protein, the largest brand, fueled overall growth with a 17% sales increase to approximately $1.97 billion, driven by distribution gains and incremental promotional activity. Volume growth of 15% was the primary driver, supplemented by targeted price increases. Dymatize sales rose 13% to about $285 million, with 23% volume growth led by international markets, though average selling prices declined due to mix shifts toward lower-priced products. All other products contributed a modest $1.3 million increase. Brand-level operating profit is not disclosed, but the single-segment structure implies that segment margin trends mirror overall operating margin.
Management highlighted several factors affecting future performance. Input costs, including raw materials, packaging, and manufacturing, are facing inflationary pressures. Additionally, announced tariffs and potential modifications could increase supply chain challenges and commodity cost volatility. The company expects these trends to have a materially adverse impact on results if mitigation efforts (such as locking in prices or raising prices to customers) are insufficient. No specific quantitative guidance was provided, but the company noted that its asset-light model requires modest capital expenditures (averaging less than 1% of net sales) and that no significant capital expenditures are planned for fiscal 2026. Liquidity remains robust, with $247.6 million available under the amended revolving credit facility, and management believes cash flows and credit facilities will satisfy future requirements. Share repurchases may continue depending on market conditions and liquidity.
Cash and cash equivalents totaled $71.8M at September 30, 2025, plus $17.3M restricted cash (primarily collateral for commodity hedges). Total debt was $1,084.3M, consisting of $840M 7.00% Senior Notes due 2030 and $250M drawn on the Revolving Credit Facility (amended to $500M capacity). The credit agreement requires a total net leverage ratio not to exceed 6.00:1; the company was in compliance. Stockholders' deficit was $(453.9)M, reflecting accumulated share repurchases.
Legal settlements from the Joint Juice litigation resulted in liabilities of $90.0M at year-end. The company recognized $69.0M of expense in fiscal 2025 related to this matter. Operating lease commitments total $58.3M, with $3.2M due within one year. Estimated future interest payments on debt through fiscal 2030 are $342.7M ($74.8M in fiscal 2026). No other material purchase commitments were disclosed.
During fiscal 2025, the company repurchased 9.0 million shares for $476.6M at an average price of $52.62. The company has paid no dividends. Net debt increased by $251.2M, reflecting $700M of new borrowings and $450M of repayments. Capital expenditures were $4.7M, or 0.2% of net sales. The company also incurred $2.1M in deferred financing fees.
BellRing operates as a single reportable segment. Net sales by product: shakes $1,892.9M, powders $366.5M, other $57.2M. Foreign sales represented 11.9% of total net sales, with Canada being the largest foreign market (35.6% of foreign sales). Three customers accounted for 34.3%, 27.5%, and 12.2% of net sales, respectively.
BellRing Brands is highly dependent on a limited number of third-party contract manufacturers and suppliers. A single manufacturer provides 46.3% of Premier Protein RTD shakes, with 28% from one facility. Further, the 11oz size packaging comes from a sole supplier, and the 11.5oz size is largely produced at a single facility. Any disruption—due to weather, labor shortages, or operational issues—could severely impair production. The company experienced such issues in fiscal 2022-2024, leading to product allocations and inventory shortfalls. Ingredient costs, especially milk proteins, are volatile and subject to inflation, weather, and market conditions, pressuring margins despite hedging attempts.
The company carries $1.09 billion in debt with variable rate exposure, making it vulnerable to rising interest rates. Covenants require a total net leverage ratio not exceeding 6.00x; failure could trigger acceleration of debt. Customer concentration is extreme: Walmart, Costco, and Amazon represent 74% of net sales, with no long-term contracts. Loss of any could materially reduce revenue. Inflation and economic downturns may further squeeze consumer demand and increase costs.
RTD shakes drive 81.7% of sales, creating a single-product dependency. Competition is intense from both national brands and private labels. The convenient nutrition category is evolving with changing consumer preferences, including weight management medications and sustainability concerns. The company must continuously innovate to maintain shelf space and brand perception.
BellRing faces several class action lawsuits related to its discontinued Joint Juice product, with $90 million accrued. Additional litigation over advertising, labeling, or food safety could result in further costs. Regulatory scrutiny from FDA, FTC, and international bodies on dietary supplements and food safety is increasing. ESG-related regulations and stakeholder expectations impose compliance costs and reputational risks.
The company has overlapping directors with Post Holdings, creating potential conflicts of interest. The spin-off from Post included tax matters agreements that could result in substantial tax liabilities if the distribution fails to qualify as tax-free. Additionally, the master services agreement with Post expires in March 2026, requiring transition of support functions.
No cash flow data available from the provided excerpt. The document contains the auditor's report and index, but the actual cash flow statement numbers are missing. Therefore, no analysis can be performed.